Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF‐&agr; and CXCL‐1

@article{Brito2018AntiallodynicAO,
  title={Antiallodynic activity of leflunomide is partially inhibited by naltrexone and glibenclamide and associated with reduced production of TNF‐\&agr; and CXCL‐1},
  author={Ana Mercy S. Brito and Adriana Martins Godin and Paulo S{\'e}rgio A. Augusto and Raquel R. Menezes and Ivo S. F. Melo and Marcela M.G.B. Dutra and Sarah O.A.M. Costa and Franciele A. Goulart and Felipe Fernandes Rodrigues and Marcela Isis Morais and Renes Resende Machado and M{\'a}rcio de Matos Coelho},
  journal={European Journal of Pharmacology},
  year={2018},
  volume={818},
  pages={17–25}
}
View on Wolters Kluwer
ncbi.nlm.nih.gov
13 Citations
Background Citations
3
Methods Citations
1

Figures from this paper

13 Citations

Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms

The results indicate that the clindamycin’s immunomodulatory effects may contribute to a pharmacological potential beyond its antibiotic property, and are associated with reduced production of TNF-α and CXCL-1 and activation of opioidergic mechanisms.

Nicorandil inhibits mechanical allodynia induced by paclitaxel by activating opioidergic and serotonergic mechanisms

RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in mice

The results of the present study demonstrate that RI75, a synthetic curcumin analogue, exhibits antiallodynic and antiedematogenic activities.

RI75, a curcumin analogue, inhibits tumor necrosis factor-α and interleukin-6 production and exhibits antiallodynic and antiedematogenic activities in mice

The results of the present study demonstrate that RI75, a synthetic curcumin analogue, exhibits antiallodynic and antiedematogenic activities.

Potential Impact of Ginsenoside Rg1 on Treatment of Paclitaxel-Induced Neuropathic Pain by TNF-α Inhibitory Action

Treatment of GRg and pregabalin ameliorated the chemotherapeutic agent i.e., PT associated pain response with the control of biomarkers changes like superoxide anion, myeloperoxidase, and TNF-α protein levels and histopathological changes.

Nitric Oxide and Opioids Involvement in Isobolographic Nsaids Antinociception.

Evaluating the possible involvement of the nitridergic pathway due to L-NAME and the opioidergic route by NTX in the antinoception induced by NSAIDs validated that the NSAIDs administered alone or in combinations produce antinociception in which other mechanisms of action must be added to the simple inhibition of COXs.

TRADITIONAL USES, PHYTOCHEMISTRY AND PHARMACOLOGICAL ACTIVITIES OF PAPAVER SOMNIFERUM WITH SPECIAL REFERENCE OF UNANI MEDICINE AN UPDATED REVIEW

An attempt is made to explore the complete information of Papaver somniferum including its phytochemistry and pharmacology including its tetrahydrobenzylisoquinolinederived classes.

A narrative review of Siddha polyherbal formulation: Amurthathi chooranam

Introduction: Early detection of kidney disease care and management helps prevent morbidity and mortality and improves cost-effectiveness and sustainability. Kidney-related diseases continue to…

A Computational Evidence of the Intermolecular Hydrogen Bonding in Leflunomide: Chemical Shielding Tensors

Electrochemical evidence of nitrate release from the nitrooxy compound 4-((nitrooxy) methyl)-3-nitrobenzoic acid and its antinociceptive and anti-inflammatory activities in mice.

References

SHOWING 1-10 OF 52 REFERENCES

Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan

Carrageenan-induced thermal hyperalgesia in the mouse: role of nerve growth factor and the mitogen-activated protein kinase pathway

Effects of leflunomide on immune responses and models of inflammation

The data concerning tyrosine kinase inhibition as a hypothetical mechanism for the non-cytotoxic and reversible antiproliferative activity of A77 1726 are in many ways, intriguing.

A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.

Results extend to mice the concept that the release of primary mediators responsible for hypernociception is preceded by a cascade of cytokines.

A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo‐oxygenase‐2 in vitro and in vivo in a substrate‐sensitive manner

In vitro and in vivo, leflunomide via A771726 can directly inhibit the activity of COX, an effect that appears blunted both by increases in substrate supply and possibly by plasma binding.

Dynamic effects of leflunomide on IL-1, IL-6, and TNF-alpha activity produced from peritoneal macrophages in adjuvant arthritis rats.

The antiinflammatory mechanisms of LEF in AA rats might be related to inhibitory level of IL-1, IL-6, and TNF-alpha from PMphi in vivo.

Mediators of the inflammation induced in the rat paw by carrageenin

It was concluded that kinins and 5‐HT contributed significantly to oedema formation during this period, and mepyramine and methysergide, at the doses used in the carrageenin experiments, completely antagonized histamine and5‐HT, respectively, and did not affect the skin responses of bradykinin.

Relevance of tumour necrosis factor‐α for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw

Results clearly indicate that the proinflammatory cytokine TNF‐α plays a critical role in the oedema formation, as well as in the mechanical allodynia and the neutrophil migration, following carrageenan administration into the mouse paw.

Active leflunomide metabolite inhibits interleukin 1β, tumour necrosis factor α, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures

Leflunomide may modulate the rheumatoid articular process by inhibition of local production of IL1β, TNFα, NO, and MMP-3.

Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide (*)

The ability of leflunomide to inhibit tyrosine kinase activity in vitro is demonstrated, and inhibition of tyosine phosphorylation events may be the mechanism by which leflinomide functions as an immunosuppressive agent.
...